A thermostable, chromatographically purified Ebola nano-VLP vaccine

BACKGROUND: Filovirus virus-like particles (VLP) are strong immunogens with the potential for development into a safe, non-infectious vaccine. However, the large size and filamentous structure of this virus has heretofore made production of such a vaccine difficult. Herein, we present new assays and...

Descripción completa

Detalles Bibliográficos
Autores principales: Carra, John H, Martins, Karen A O, Schokman, Rowena D, Robinson, Camenzind G, Steffens, Jesse T, Bavari, Sina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502941/
https://www.ncbi.nlm.nih.gov/pubmed/26174690
http://dx.doi.org/10.1186/s12967-015-0593-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502941/
https://www.ncbi.nlm.nih.gov/pubmed/26174690
http://dx.doi.org/10.1186/s12967-015-0593-y

Ejemplares similares